Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Dec;52(4):1206-1210.
doi: 10.1007/s12029-021-00745-4. Epub 2021 Nov 11.

Hepatitis B Before and After Hepatocellular Carcinoma

Murat Harputluoglu  1 , Brian I Carr  2
Affiliations
Review

Hepatitis B Before and After Hepatocellular Carcinoma

Murat Harputluoglu et al. J Gastrointest Cancer. 2021 Dec.

Abstract

Hepatitis B virus (HBV) is the one of most common causes of the hepatocellular carcinoma (HCC), especially in eastern world. The aim of this review is to try to understand the relationship between HBV and HCC and to reveal the role of prevention and treatment of HBV infection in reducing the incidence of HCC. Strategies to prevent HCC due to HBV can be classified into three categories. These are primary, secondary, and tertiary preventions. Hepatitis B vaccine is now in the most vital position in preventing HBV-associated HCC. In patients with chronic hepatitis B infection, suppressing viral load with potent antivirals such as tenofovir disoproxil fumarate (TDF) and entecavir (ETV) prevents the development of HCC and improves prognosis by reducing recurrence after HCC treatments. There is currently no clear consensus on which of these drugs should be preferred. Although data on tenofovir alafenamide (TAF) are scarce, available data with TDF suggest that TAF therapy will also be a strong actor for HCC.

Keywords: Hepatitis B; Hepatocellular carcinoma; Prevention.

PubMed Disclaimer

References

    1. Asafo-Agyei KO, Samant H. Hepatocellular carcinoma. Aug 8. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2021 PMID: 32644603.
    1. Suresh D, Srinivas AN, Kumar DP. Etiology of hepatocellular carcinoma: special focus on fatty liver disease. Front Oncol. 2020;30: 601710. https://doi.org/10.3389/fonc.2020.601710.PMID:33330100;PMCID:PMC7734960 . - DOI
    1. Madihi S, Syed H, Lazar F, Zyad A, Benani A. A systematic review of the current hepatitis B viral infection and hepatocellular carcinoma situation in Mediterranean countries. Biomed Res Int. 2020;2020:7027169. https://doi.org/10.1155/2020/7027169.PMID:32626758;PMCID:PMC7305551 . - DOI - PubMed - PMC
    1. Baecker A, Liu X, La Vecchia C, Zhang ZF. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev. 2018;27:205–12. https://doi.org/10.1097/CEJ.0000000000000428.PMID:29489473;PMCID:PMC5876122 . - DOI - PubMed - PMC
    1. Varbobitis I, Papatheodoridis GV. The assessment of hepatocellular carcinoma risk in patients with chronic hepatitis B under antiviral therapy. Clin Mol Hepatol. 2016;22:319–326. https://doi.org/10.3350/cmh.2016.0045 . Epub 2016 Sep 25. PMID: 27729632; PMCID: PMC5066383.

MeSH terms

LinkOut - more resources